Q32 Bio eases after starting $200 mln equity offering

Q32 Bio

13/07/2026 21:13

** Shares of Q32 Bio QTTB.O down 4.1% post-market to $20.51 as co looks to raise equity
** QTTB commences $200 mln offering comprising stock and pre-funded warrants
** Morgan Stanley, Jefferies and Cantor Fitzgerald joint bookrunners
** QTTB shares soared 90.7% to close at $21.38 on Mon after co said its hair-loss drug, bempikibart, showed hair regrowth in mid-stage study
** Co intends to use net offering proceeds for working capital, R&D-related expenses, clinical development and commercialization efforts including for supporting advancement of bempikibart into future clinical trials
** At close, QTTB shares have surged more than sixfold YTD

(Lance Tupper is a Reuters market analyst. The views expressed are his own)
((lance.tupper@tr.com 1-646-279-6380))